UC Law lecture to explore how fintech is transforming financial markets
Event Information (passed)
Saule T. Omarova, Beth and Marc Goldberg Professor of Law, Cornell Law School, will discuss the topic “Financial Technology as a Regulatory Challenge” at her upcoming College of Law lecture. This event, the 2024 Distinguished Visiting Professor Lecture, will be held at 12:15 p.m., Thursday, Jan. 11, in Rm. 160 at the College of Law (2925 Campus Green Drive).
The lecture is free and open to the public. Registration is appreciated. Please register via the link below.
CLE: Application for 1.0 hours of CLE have been approved for KY. 1.0 hrs of CLE have been submitted for OH. Approval is expected.
About the Lecture
Time passes differently under the ancient United States Constitution. Constitutional time in financial technology, or fintech, is visibly transforming today’s financial markets. Less visibly, it is also gradually reshaping our collective understanding of finance as simply another sphere of applied information technology. Yet, technology is merely a tool. How to use it, for what purposes and to what effects, is a choice. What this choice involves in the context of fintech is a complex and politically salient question at the heart of the current academic and policy debate. To answer this question, however, it is critical to develop a coherent conceptual view of fintech as a systemic, as opposed to purely transactional, phenomenon. Widening the analysis to encompass such an explicitly macro-systemic perspective enables us to gain a better understanding of the fundamental challenges the rise of fintech presents to the very enterprise of financial regulation.
About the Lecturer
Professor Saule Omarova
Professor Saule T. Omarova specializes in the regulation of financial institutions, banking law, international finance, and corporate finance. Before joining Cornell Law School in 2014, she was the George R. Ward Associate Professor of Law at the University of North Carolina School of Law. Throughout her career, Professor Omarova has served in many positions, including Visiting Professor at Yale University Law School, Senior Fellow at the Roosevelt Institute, Senior Fellow at the Berggruen Institute, Distinguished Visiting Professor at the University of Torino (Italy), and Distinguished Visiting Professor at the University of Toronto (Canada).
Professor Omarova has authored numerous scholarly articles, which have been published in the Vanderbilt Law Review, the Journal of Financial Regulation, Washington University Journal of Law and Policy, Yale Journal on Regulation, Cornell Law Review, Washington University Law Review, the Miami Law Review, among many other journals and publications. In addition, she has authored or co-authored many white papers, book chapters and reports.
Prior to joining academia, Professor Omarova practiced law in the Financial Institutions Group of Davis, Polk, & Wardwell, where she specialized in a wide variety of corporate transactions and advisory work in the area of financial regulation. In 2006-2007, she served at the U.S. Department of the Treasury as a Special Advisor for Regulatory Policy to the Under Secretary for Domestic Finance.
Professor Omarova graduated from Moscow State University with a degree in Philosophy. She received her JD from Northwestern University School of Law, and PhD from the University of Wisconsin at Madison.
Lead photo: istockphoto.com; Omarova photo: provided
Tags
Related Stories
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.
Weight loss drugs help, but not on their own
January 5, 2026
Millions of Americans are on one type of weight loss drug or another, and a University of Cincinnati physician says there are things to know as we enter the new year. Malti Vij, MD, adjunct associate professor in the Department of Internal Medicine and provider at UC Health Primary Care in Mason, recently spoke to 91.7 WVXU News.